Inactive Instrument

Highlights Venn Life Sciences Holdings London S.E.

Equities

HVIVO swings to profit and commences annual dividends as outlook rosy	Apr. 09	AN
HVIVO plc Provides Revenue Guidance for the Year 2024	Apr. 09	CI
HVIVO plc Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 09	CI
European Green Transition starts trading on London's AIM market	Apr. 08	AN
Investment firm European Green Transition plans listing on AIM	Mar. 18	AN
HVIVO Chair and non-exec director sell 30.0 million shares	Feb. 14	AN
HVIVO directors to sell total of 14 million shares	Feb. 14	AN
Hvivo Shareholders Plan Secondary Placing to Sell 14 Million Shares	Feb. 14	MT
HVIVO shares up after "record year" across all metrics	Jan. 30	AN
Hvivo Wins GBP6 Million Antiviral Testing Contract	Jan. 02	MT
HVIVO inks GBP6.3 million deal to test common cold treatment	Jan. 02	AN
HVIVO plc Signs £6.3 Million Human Challenge Study Model	Jan. 02	CI
Hvivo Secures GBP17 Million Contract for RSV Antiviral Drug Testing; Stock Surges	Dec. 13	MT
HVIVO signs deal to test RSV antiviral drug candidate with study model	Dec. 13	AN
HVIVO interim profit jumps on revenue increase; ups full-year guidance	23-09-12	AN
UK Stocks-Factors to watch on Sept 12	23-09-12	RE
Earnings Flash (HVO.L) HVIVO Reports H1 Revenue GBP27.3M	23-09-12	MT
Earnings Flash (HVO.L) HVIVO Posts H1 EPS GBX0.58	23-09-12	MT
HVIVO plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-12	CI
HVIVO plc Increases Revenue Guidance for 2023	23-09-12	CI

No results for this search